JPH05368B2 - - Google Patents
Info
- Publication number
- JPH05368B2 JPH05368B2 JP62057859A JP5785987A JPH05368B2 JP H05368 B2 JPH05368 B2 JP H05368B2 JP 62057859 A JP62057859 A JP 62057859A JP 5785987 A JP5785987 A JP 5785987A JP H05368 B2 JPH05368 B2 JP H05368B2
- Authority
- JP
- Japan
- Prior art keywords
- oxypurinol
- pharmaceutical composition
- tissue
- amino acid
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB868606283A GB8606283D0 (en) | 1986-03-13 | 1986-03-13 | Cell protection |
| GB8606283 | 1986-03-13 | ||
| GB8623835 | 1986-10-03 | ||
| GB8701976 | 1987-01-29 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS62230730A JPS62230730A (ja) | 1987-10-09 |
| JPH05368B2 true JPH05368B2 (cs) | 1993-01-05 |
Family
ID=10594577
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP62057859A Granted JPS62230730A (ja) | 1986-03-13 | 1987-03-12 | 新規な医薬組成物 |
| JP5869987A Pending JPS62230725A (ja) | 1986-03-13 | 1987-03-13 | 細胞防護剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP5869987A Pending JPS62230725A (ja) | 1986-03-13 | 1987-03-13 | 細胞防護剤 |
Country Status (3)
| Country | Link |
|---|---|
| JP (2) | JPS62230730A (cs) |
| GB (1) | GB8606283D0 (cs) |
| ZA (1) | ZA871814B (cs) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1991007385A1 (en) * | 1989-11-18 | 1991-05-30 | Schering Agrochemicals Limited | Preparation of propenoic acid derivatives |
-
1986
- 1986-03-13 GB GB868606283A patent/GB8606283D0/en active Pending
-
1987
- 1987-03-12 ZA ZA871814A patent/ZA871814B/xx unknown
- 1987-03-12 JP JP62057859A patent/JPS62230730A/ja active Granted
- 1987-03-13 JP JP5869987A patent/JPS62230725A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| GB8606283D0 (en) | 1986-04-16 |
| JPS62230725A (ja) | 1987-10-09 |
| JPS62230730A (ja) | 1987-10-09 |
| ZA871814B (en) | 1988-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU600724B2 (en) | Novel combination | |
| CA2171266C (en) | Stable transglutaminase preparations and processes for producing them | |
| US5084273A (en) | Composition of anticoagulants | |
| JPH0759517B2 (ja) | 組織プラスミノーゲン活性化因子含有医薬組成物 | |
| EP0123304A2 (en) | A method for stabilizing tissue plasminogen activator and a stable aqueous solution or powder containing the same | |
| DK167738B1 (da) | Fremgangsmaade til fremstilling af en oploesning med hoej specifik rumfangsaktivitet af et protein med vaevs-plasminogenaktivator(t-pa)-aktivitet, oploesning der indeholder protein med t-pa-aktivitet, og anvendelsen af oploesningen inden for human- og veterinaermedicinen | |
| US5202117A (en) | Method of treating thrombi with g-csf | |
| JPH0714886B2 (ja) | 安定化されたヒト組織プラスミノゲン活性化因子組成物 | |
| HU200695B (en) | Process for producing stable pharmaceutical compositions comprising tissural plasminogene activator | |
| CA1297009C (en) | Use of t-pa for the inhibition of damage to jeopardized tissue during reperfusion in a mammal | |
| JPH0273022A (ja) | 組織プラスミノーゲン活性化因子を用いた薬学的製剤 | |
| JPH03141221A (ja) | トランスグルタミナーゼ阻害剤としての一定のイミダゾール化合物類 | |
| EP0257859B1 (en) | Novel combination | |
| AU598239B2 (en) | The application of tissue plasminogen activator and oxypurinol in dissolving blood clots and in preventing damage to ischaemic tissue during reperfusion | |
| JPH05368B2 (cs) | ||
| JPH01240186A (ja) | フィブリン特異性２本鎖プラスミノーゲンアクチベーター | |
| CA2475738A1 (en) | Activated protein c formulations | |
| US5342616A (en) | Method of administering tissue plasminogen activator | |
| JPS6226233A (ja) | 組織プラスミノ−ゲン活性化因子含有医薬組成物 | |
| US20020151481A1 (en) | MMP-2 propeptide for use as antiangiogenic or antitumor agent | |
| US7115559B2 (en) | Method for treating coumarin-induced hemorrhage | |
| EP0352897A1 (en) | TPA-containing medicaments | |
| JPS60248621A (ja) | 一本鎖組織プラスミノ−ゲンアクチベ−タ−の安定化方法 | |
| Robison et al. | Activators of Plasminogen | |
| JPH049334A (ja) | 線溶活性増強剤 |